United States
Fort Worth, Texas, 76134, United States
NCT Number: NCT00333203
The purpose of this study is to evaluate the safety of Next Generation Ophthalmic Irrigating Solution (NGOIS) compared to BSS PLUS for use during surgery for removal of epimacular membrane and vitrectomy.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 3
Fort Worth, Texas, 76134, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Volume sufficient to irrigate adequately during cataract surgery
Volume sufficient to irrigate adequately during cataract surgery
Looking for future studies?
Notify MeAlcon Research
Industry
Clinical Evaluation of the Safety of Next Generation Ophthalmic Irrigating Solution Compared to BSS Plus for Use During Surgery for Removal of Epimacular Membrane and Vitrectomy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05276063
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Beverly Hills, California, United States
View Trial DetailsNCT06177639
Eye Diseases
Durham, North Carolina, United States
View Trial DetailsNCT04127006
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases
San Francisco, California, United States
View Trial DetailsNCT06455826
Eye Diseases, Eye Diseases, Hereditary
Jacksonville, Florida, United States
View Trial Details